Pictet Asset Management’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24M Sell
1,323,179
-60,596
-4% -$980K 0.03% 461
2025
Q4
$24.4M Sell
1,383,775
-220,388
-14% -$4.15M 0.02% 485
2025
Q3
$33.5M Sell
1,604,163
-559,710
-26% -$13.6M 0.03% 406
2025
Q2
$45.6M Sell
2,163,873
-497,731
-19% -$11.4M 0.05% 334
2025
Q1
$52.1M Buy
2,661,604
+1,274,357
+92% +$25.6M 0.06% 296
2024
Q4
$24.8M Buy
1,387,247
+695,843
+101% +$13.5M 0.03% 443
2024
Q3
$14.4M Sell
691,404
-17,219
-2% -$241K 0.02% 564
2024
Q2
$5.53M Buy
708,623
+698,560
+6,942% +$3.77M 0.01% 766
2024
Q1
$41.7K Buy
+10,063
New +$40K ﹤0.01% 1945

Other funds holding SMMT